A descriptive economic analysis of spending patterns using administrative data; documents trends but lacks comparative design, causal inference, or clinical outcomes to support practice change.
Reported
Total prostate cancer–related exp…$504 million
Total prostate cancer–related exp…$1.9 billion
Systemic therapy expenditures 2012$142 million (28.1%)